Chemoinformaics analysis of BUTANOIC ACID, 2-METHYL-, 4-METHOXY-2-(3-METHYLOXIRANYL)PHENYL ESTER
| Molecular Weight | 264.321 | nRot | 5 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 10 |
| Exact Molecular Weight | 264.136 | nRing | 2 |
| Solubility: LogS | -4.114 | nHRing | 1 |
| Solubility: LogP | 3.477 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 41.5939 |
| nHD | 0 | BPOL | 26.1401 |
| QED | 0.466 |
| Synth | 3.233 |
| Natural Product Likeliness | 0.859 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.671 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.659 |
| MDCK | 0.0000227 |
| BBB | 0.968 |
| PPB | 0.790972 |
| VDSS | 0.767 |
| FU | 0.168058 |
| CYP1A2-inh | 0.615 |
| CYP1A2-sub | 0.876 |
| CYP2c19-inh | 0.819 |
| CYP2c19-sub | 0.899 |
| CYP2c9-inh | 0.425 |
| CYP2c9-sub | 0.711 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.871 |
| CYP3a4-inh | 0.52 |
| CYP3a4-sub | 0.578 |
| CL | 9.882 |
| T12 | 0.215 |
| hERG | 0.01 |
| Ames | 0.422 |
| ROA | 0.138 |
| SkinSen | 0.603 |
| Carcinogencity | 0.455 |
| EI | 0.43 |
| Respiratory | 0.756 |
| NR-Aromatase | 0.082 |
| Antiviral | Yes |
| Prediction | 0.826529 |